Philip Morris International Inc. (PM)
Philip Morris: Quality Growth And What To Look For Going Forward
Philip Morris' Q2 Zyn volumes missed expectations in the US, but strong overall SFB growth reinforces my long-term buy thesis as the company pivots to smoke-free products. SFB now represents 23% of volumes and 43% of gross margin, with superior unit economics—each SFB unit is twice as profitable as combustibles. Key metrics to track: sustained positive volume growth, SFB gross margin share surpassing 50%, and maintaining strong SFB unit economics without margin sacrifice.
Philip Morris Transformation Accelerates With IQOS and ZYN Growth
PM's second-quarter results show smoke-free gains lifting revenues and profit, even as cigarette volumes continue to decline.
Philip Morris: Historically Low Dividend Yield Justifies A Sell
Philip Morris International's growth is driven by smoke-free products like IQOS and ZYN, with strong sales momentum post-Swedish Match acquisition. Despite robust operational performance and a raised outlook, the stock's valuation appears stretched with an EV/FCF of 31x and a historically low 3.1% dividend yield. Much of the recent growth seems to be already priced in, and further upside seems limited, making the risk/reward profile unattractive at current levels.
Philip Morris (PM) Up 5% Since Last Earnings Report: Can It Continue?
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?
Philip Morris: Further Shareholder Returns Upcoming
Philip Morris is the world's largest publicly traded 'sin' stock, valued at over $250 billion. The company has a strong track record of outperforming the market, driven by its shareholder return focus. Recent earnings suggest PM still has significant growth potential ahead.
PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?
Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.
Philip Morris Aims for $2B Cost Savings by 2026: How Close Is It?
PM has already captured $1.2 billion in savings by mid-2025, keeping it on track to hit its $2 billion cost-cutting target by 2026.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth? (Revised)
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Night Watch Investment Management Q2 2025 Position Updates
Haypp remains our largest position, offering rapid growth, a defensible moat, and high-margin insights business in the booming nicotine pouch market. X-FAB is attractively valued with two near-term catalysts: capacity expansion and a new dividend, plus strong insider ownership and overlooked profit growth. We exited Dream International after a 160% return, as the stock is no longer cheap post-Labubu news and lacks a clear catalyst for further upside.
Here's Why Philip Morris (PM) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
PM hikes its 2025 EPS guidance as smoke-free products like IQOS and ZYN boost the second-quarter performance.
